Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program
Qiuhua Li(Pfizer (United States)), Shou‐Jiang Gao(UPMC Hillman Cancer Center), Fengchun Ye(China Nerin Engineering (China)), Fuchun Zhou(Capital Medical University)
Cited by 78
Related Papers
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
|Journal of Medicinal Chemistry|2011|924
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|630
FLIP-mediated autophagy regulation in cell death control
|Nature Cell Biology|2009|398
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
|Advances in Virology|2011|170